Physician profile
Steven A Levi
NPI 1902859150
$42,931.72
in general payments reported to CMS, 2019-2025
36 companies · $1,905 in 2025
The $1,905 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $6,972 · 2021: $11K · 2022: $4,809 · 2023: $696 · 2024: $974 · 2025: $1,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,323 · Travel and Lodging: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,323.46 |
| Travel and Lodging | $251.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $34,234.74 | 2019-2024 | Xarelto |
| Abbott Laboratories | $4,110.54 | 2019-2025 | Aveir, Amplatzer Amulet, Cardiomems |
| Boston Scientific Corporation | $1,257.30 | 2019-2025 | Watchman Flx, General - Therapies, Farapulse |
| Novartis Pharmaceuticals Corporation | $450.64 | 2019-2025 | |
| Biosense Webster, INC. | $389.02 | 2019-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $292.89 | 2019-2025 | Lifevest |
| Pfizer INC. | $263.60 | 2019-2025 | |
| Amgen INC. | $247.70 | 2019-2025 | Repatha, Repatha |
| Atricure, INC. | $206.72 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $181.01 | 2019-2022 | |
| Zoll Respicardia, INC. | $169.08 | 2021 | |
| Impulse Dynamics (USA) INC. | $164.50 | 2022-2025 | Optimizer |
| Medtronic Vascular, INC. | $105.85 | 2019-2020 | |
| Medtronic, INC. | $99.30 | 2021-2025 | Affera Mapping System, V-Loc 180, Mycarelink |
| Merck Sharp & Dohme LLC | $84.72 | 2021-2024 | Verquvo |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Levi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.